Martin D. Phillips
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 4
- Hematology top 5%
- Platelet Disorders and Treatments 5
- Hemophilia Treatment and Research 3
- Blood Coagulation and Thrombosis Mechanisms 2
- Blood groups and transfusion 2
- Oncology top 10%
- Biotechnology top 10%
- Cancer Research and Treatments 2
- Internal Medicine top 10%
-
- Heparin-Induced Thrombocytopenia and Thrombosis 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Susan C. WeilCharles SchweizerRaffit HassanIra PastanDeborah K. ArmstrongRobert L. ColemanLloyd J. OldSteven J. Cohen
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Martin D. Phillips
15 papers receiving 936 citations
Peers
Comparison fields: 5 of 65
- Reproductive Medicine 177
- Hematology 192
- Oncology 349
- Biotechnology 88
- Internal Medicine 35
Countries citing papers authored by Martin D. Phillips
This map shows the geographic impact of Martin D. Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin D. Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin D. Phillips more than expected).
Fields of papers citing papers by Martin D. Phillips
This network shows the impact of papers produced by Martin D. Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin D. Phillips. The network helps show where Martin D. Phillips may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin D. Phillips, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2013 | 114 | |
| 3 | 2012 | 15 | |
| 4 | 2012 | 6 | |
| 5 | 2010 | 133 | |
| 6 | 2010 | 160 | |
| 7 | Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. | 2007 | 155 |
| 8 | Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. | 2007 | 113 |
| 9 | 2001 | 29 | |
| 10 | 1998 | 10 | |
| 11 | 1998 | 16 | |
| 12 | 1997 | 79 | |
| 13 | 1995 | 93 | |
| 14 | 1995 | 32 | |
| 15 | 1993 | 16 | |
| 16 | 1991 | 7 |
About Martin D. Phillips
Martin D. Phillips is a scholar working on Hematology, Reproductive Medicine and Genetics, having authored 16 papers that have together received 978 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Hemophilia Treatment and Research (3 papers), Cancer Research and Treatments (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Reproductive Medicine (177 citations), Hematology (192 citations) and Oncology (349 citations). Martin D. Phillips has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Susan C. Weil, Charles Schweizer, Raffit Hassan, Ira Pastan, Deborah K. Armstrong, Robert L. Coleman, Lloyd J. Old, Steven J. Cohen, Elad Sharon and Daniel A. Laheru.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.